APA (7th ed.) Citation

V, C., M, L. G., C, T., J, R., F, S., A, C., . . . J, S. (2024). Safety and immunogenicity of Ad26.COV2.S in adults: A randomised, double-blind, placebo-controlled Phase 2a dose-finding study. Vaccine, 42(16), 3536. https://doi.org/10.1016/j.vaccine.2024.04.059

Chicago Style (17th ed.) Citation

V, Cárdenas, et al. "Safety and Immunogenicity of Ad26.COV2.S in Adults: A Randomised, Double-blind, Placebo-controlled Phase 2a Dose-finding Study." Vaccine 42, no. 16 (2024): 3536. https://doi.org/10.1016/j.vaccine.2024.04.059.

MLA (9th ed.) Citation

V, Cárdenas, et al. "Safety and Immunogenicity of Ad26.COV2.S in Adults: A Randomised, Double-blind, Placebo-controlled Phase 2a Dose-finding Study." Vaccine, vol. 42, no. 16, 2024, p. 3536, https://doi.org/10.1016/j.vaccine.2024.04.059.